SACCRANTA SACCHAROMYCES BOULARDII 250MG CAPSULES

Country: Malaysia

Language: English

Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Active ingredient:

SACCHAROMYCES BOULARDII

Available from:

SYNERRV SDN BHD

INN (International Name):

SACCHAROMYCES BOULARDII

Units in package:

100 Capsules

Manufactured by:

Allianz Biosciences Private Limited

Summary of Product characteristics

SIZE : 100 X 225 MM
Manufactured in India by :
R.S. No. 55/ 1, 2 & 3, Whirlpool Road,
Thiruvandar koil, Puducherry - 605102.
Imported and Marketed by Product Holder
SO-29-2, Menara 1, KL Eco City,
Jalan Bangsar, Kg Haji Abdullah Hukum,
59200 Kuala Lumpur,
Malaysia
SACCRANTA
SACCHAROMYCES BOULARDII
250 mg CAPSULES
Saccharomyces boulardii is a yeast, which is a type of fungus.
PRODUCT DESCRIPTION
Light beige coloured granules filled in a white size '1' hard
coloured gelatine
capsule
INDICATION :
As a Health Supplement
RECOMMENDED DOSE
Adult: Take one capsule twice a day after meal or as recommended by
your
doctor or pharmacist
ROUTE OF ADMINISTRATION
Oral
CONTRAINDICATION
Do not take this product if you are immunocompromised (altered/
weakened
immune system) or have central venous catheter
Contraindications:
Patients having a central venous catheter. Critically ill
patients or immunocompromised patients due to a risk of fungaemia (See
section Warnings & Precautions)
WARNINGS AND PRECAUTIONS
Keep out of reach of children
Jauhi dari kanak-kanak
Please consult your doctor/ pharmacist before using this product
There have been very rare cases of fungaemia reported mostly in
patients
with central venous catheter, critically ill or immuno-compromised
patients,
most often resulting in pyrexia. In most cases, the outcome has been
satisfactory after cessation of treatment by Saccharomyces boulardii,
administration of antifungal treatment and removal of the catheter
when
necessary. However, the outcome was fatal in some critically ill
patients (see
Section Contraindications & Section Adverse Effects / Undesirable
Effects)
INTERACTIONS WITH OTHER MEDICAMENTS
Unknown
PREGNANCY AND LACTATION
This product is not intended to be used by pregnant or lactating women
ADVERSE EFFECTS/ UNDESIRABLE EFFECTS
Infections
and
infestations:
Very
rare:
Fungaemia
in
patients
with
a
central
venous catheter and in critically ill or immunocompromised patients
(see Section
Warnings & Precautions)
SYMPTOMS AND TREATMENT OF OVERDOSE
Unknown
EFFECTS